RT @InnovOncology: Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Re…
255,795 followers
2,464 followers
Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase Inhibitor @ASCO @JCO_ASCO @JCOOP_ASCO #Ovariancancer
966 followers
Congratulations to Angelina Tjokrowidjaja on your public disclosure! We’re proud to facilitate your access to data #ClinicalResearch https://t.co/ml9Aa3zBpq @Sydney_Uni
1,625 followers
RT @JCO_ASCO: In women with PSROC on maintenance PARPi, approximately 1 in 2 with RECIST PD did not have CA-125 PD: https://t.co/mRMz5SnvyY